Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post on LinkedIn:
“Cancer Patients are at greater risk for blood clots, yet many patients aren’t aware of this increased risk. It’s especially important that Clinical Trials monitor and report accurate results.”
More posts featuring Ginny Mason on OncoDaily.